Cutaneous Involvement in Plasma Cell Myeloma: Report of a Case
Plasma cellmyeloma constitutes about 10% of all hematologicmalignancies. Metastatic cutaneous lesions without underlying bony involvement are rare and associated with advanced disease, poor prognosis and high tumor burden. IgG is the most common subtype and IgD is believed to have a more aggressiv...
Main Authors: | Farid Kosari, Hiva Saffar, Sanaz Aghaei |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2017-01-01
|
Series: | Acta Medica Iranica |
Subjects: | |
Online Access: | https://acta.tums.ac.ir/index.php/acta/article/view/6112 |
Similar Items
-
Detection of intracellular IgD using flow cytometry could be a novel and supplementary method to diagnose IgD multiple myeloma
by: Wei Wang, et al.
Published: (2018-06-01) -
Regulation of T Cell Activities in Rheumatoid Arthritis by the Novel Fusion Protein IgD-Fc-Ig
by: Jing Zhang, et al.
Published: (2020-05-01) -
Light chain deposition disease involving kidney and liver in a patient with IgD myeloma
by: Takafumi Tsushima, et al.
Published: (2021-01-01) -
N-glycosylation of serum proteins for the assessment of patients with IgD multiple myeloma
by: Jie Chen, et al.
Published: (2017-12-01) -
Characterising the Phenotypic Diversity of Antigen-Specific Memory B Cells Before and After Vaccination
by: M. Christian Tjiam, et al.
Published: (2021-09-01)